Document is current
Any future updates will be listed below
-
Authors
Zhang, Jinsui https://orcid.org/0009-0008-0527-8702
Xia, Zemin https://orcid.org/0009-0009-2266-7424
Guo, Wanjie https://orcid.org/0009-0009-5503-8392
Ren, Xiaoxiao https://orcid.org/0009-0001-3255-998X
Liu, Fang https://orcid.org/0009-0003-4069-7885
Ratnaparkhi, Gargi https://orcid.org/0009-0005-8636-1601
Pagada, Amit https://orcid.org/0009-0003-8771-7273
Subramanian, Subhashini https://orcid.org/0000-0002-2682-0993
Hu, Min https://orcid.org/0000-0002-0788-8765
Chen, Wen https://orcid.org/0000-0002-1179-4163
-
Funding
Funding for this research was provided by:
Beijing Novartis Pharma
- License Information
-
More Information
Article History
Received: 7 August 2023
Accepted: 13 September 2023
First Online: 23 September 2023
Declarations
:
: Jinsui Zhang, Zemin Xia, Min Hu and Wen Chen declare that they have no conflicts of interest. Wanjie Guo, Xiaoxiao Ren and Fang Liu are employees of Novartis Pharmaceuticals, Beijing, China. Gargi Ratnaparkhi, Amit Pagada and Subhashini Subramanian are employees of Novartis Healthcare Pvt. Ltd., Hyderabad, India.
: This article is based on mathematical modeling with inputs informed primarily by previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
